阳性抗脂抗体:观察还是治疗?
Bogna Grygiel-Górniak1, Łukasz Mazurkiewicz2
1Department of Rheumatology, Rehabilitation and Internal Diseases, Poznan University of Medical Sciences, Fredry 10, 61-701, Poznan, Poland. bgrygiel@ump.edu.pl.
Journal of thrombosis and thrombolysis
|June 1, 2023
概括
抗脂抗体 (APLA) 与血栓形成风险有关,即使在没有抗脂综合征 (APS) 的人群中也是如此. 早期血栓预防是预防凝块和降低APLA阳性个体的发病率的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 类风湿病学 类风湿病学
背景情况:
- 抗脂抗体 (APLA) 向脂结合蛋白,导致血栓事件.
- 包括抗β2GPI,抗CL和狼抗凝剂在内的APLA是抗脂综合征 (APS) 的诊断标志物.
- 除了APS之外,APLAs还存在于各种疾病中,例如风湿性疾病,癌症,感染,神经系统疾病,甚至在健康个体中.
研究的目的:
- 分析未被诊断为APS的患者中APLA的临床情况和后果.
- 讨论各种APLA的患病率,病因学,分子背景和原血栓性质.
- 根据最近的建议,提出一种新的APLA在不同临床条件和器官并发症中的管理方法.
主要方法:
- 文献审查和对APLAs现有数据的分析.
- 讨论不同APLA的分子机制和原血栓性质.
- 对管理APLA阳性患者的当前建议的综合.
主要成果:
- 在不同患者群体中检测到APLA,包括那些患有类风湿性疾病,恶性瘤,感染和神经系统疾病的患者.
- 慢性无症状APLA在老年人和患有慢性疾病的人群中很常见;特定的APLA可以表明癌症的进展.
- 在6%的孕妇中存在APLA,与妊娠并发症相关,并且具有不同的前血栓潜力.
结论:
- 存在APLAs,特别是在临床上以前未见过的个体中,需要仔细的临床考虑.
- 及时的血栓预防对于缓解血栓形成和降低APLA阳性患者的发病率至关重要.
- 了解APLA的各种临床影响可以指导适当的管理策略.
相关概念视频
Venous Thrombosis III: Interprofessional Care
12
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
12
Anticoagulant Drugs: Low-Molecular-Weight Heparins
773
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
773
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
570
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
570
Peripheral Artery Disease III: Interprofessional Care
14
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
14
Acute Pyelonephritis II: Diagnostic Studies and Management
20
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
20
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
15
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
15


